Details

Autor(en) / Beteiligte

• Bergman, Jack
• Roof, Rebecca A
• Furman, Cheryse A
• Conroy, Jennie L
• Mello, Nancy K
• Sibley, David R
• Skolnick, Phil

Titel

Modification of cocaine self-administration by buspirone (buspar registered ): potential involvement of D sub(3) and D sub(4) dopamine receptors

Ist Teil von

• The international journal of neuropsychopharmacology, 2013-03, Vol.16 (2), p.445-458

Erscheinungsjahr

2013

Link zum Volltext

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Converging lines of evidence indicate that elevations in synaptic dopamine levels play a pivotal role in the reinforcing effects of cocaine, which are associated with its abuse liability. This evidence has led to the exploration of dopamine receptor blockers as pharmacotherapy for cocaine addiction. While neither D sub(1) nor D sub(2) receptor antagonists have proven effective, medications acting at two other potential targets, D sub(3) and D sub(4) receptors, have yet to be explored for this indication in the clinic. Buspirone, a 5-HT sub(1A) partial agonist approved for the treatment of anxiety, has been reported to also bind with high affinity to D sub(3) and D sub(4) receptors. In view of this biochemical profile, the present research was conducted to examine both the functional effects of buspirone on these receptors and, in non-human primates, its ability to modify the reinforcing effects of i.v. cocaine in a behaviourally selective manner. Radioligand binding studies confirmed that buspirone binds with high affinity to recombinant human D sub(3) and D sub(4) receptors (~98 and ~29 nm respectively). Live cell functional assays also revealed that buspirone, and its metabolites, function as antagonists at both D sub(3) and D sub(4) receptors. In behavioural studies, doses of buspirone that had inconsistent effects on food-maintained responding (0.1 or 0.3 mg/kg i.m.) produced a marked downward shift in the dose-effect function for cocaine-maintained behaviour, reflecting substantial decreases in self-administration of one or more unit doses of i.v. cocaine in each subject. These results support the further evaluation of buspirone as a candidate medication for the management of cocaine addiction.